PemBlog - January 06, 2021 - By Brad Sobolewski
"The Bottom Line – A single 500mg IM dose of ceftriaxone is effective for treating uncomplicated urogenital, anorectal, and pharyngeal gonorrhea infections
Citing increasing resistance and antibiotic stewardship the CDC has revised its recommendations for the treatment of gonorrhea. Recall that the previous treatment recommendation from 2010 included a dose of 250mg ceftriaxone given as an intramuscular injection and a single 1g oral doze of azithromycin for the treatment of gonorrhea. N. gonorrhoeae continues to be highly susceptible to ceftriaxone – but azithromycin resistance is increasing. There are some updated recommendations which I’ll briefly discuss below. You can read the full report in the MMWR..."